drugset / Trial / NCT05518513

Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty

NCT05518513 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators believed the analgesic efficacy of adductor canal block on patients receiving total knee arthroplasty. However, the analgesic effects of different delivery regimens and duration of effects are variable. The investigators hypothesize that using continuous infusion and shorter interval bolus of local anesthetics to perform adductor canal block will reduce pain scale and opioid consumption in patients receiving total knee arthroplasty compared with longer interval bolus of local anesthetics.

Timeline

Start
2022-11-01
Primary completion
2024-06-30
Completion
2024-09-30

Outcome

Missed primary endpoint

paper Changing the mode of administration for an ACB from continuous infusion to repeated intermittent boluses did not decrease opioid consumption, pain, nor mobility. PMID 29293181 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 3.5 ml —
Subject Bupivacaine Other / unclassified 21 ml —

Indications